Patents by Inventor Paul J. Niebes

Paul J. Niebes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4639468
    Abstract: A glycinamide derivative of the general formula I: ##STR1## wherein: R is a linear or ramified alkyl group C.sub.5 -C.sub.18, a linear or ramified alkenyl group C.sub.5, C.sub.6, C.sub.7, C.sub.8, C.sub.9, C.sub.10, C.sub.11, C.sub.12, C.sub.13, C.sub.14, C.sub.15, C.sub.16, C.sub.17 or C.sub.18, a linear or ramified alkynyl group C.sub.4 -C.sub.10, a linear or ramified acyl group C.sub.4 -C.sub.18, a linear or ramified alkyl group C.sub.1 -C.sub.10, substituted by a phenoxy group, by a hydroxy radical, by an acetoxy radical, by a carboxy radical, by a linear or ramified alkoxycarbonyl group C.sub.1 -C.sub.4, by a carbonyl radical, by a carboxaldehyde group, by an acetal or cetal group, by one or more phenyl groups, by one or more phenyl groups substituted by a halogen atom such as fluorine, chlorine or bromine,R.sub.1 represents hydrogen, a linear or ramified alkyl group C.sub.1, C.sub.2, C.sub.3, C.sub.4, C.sub.5, C.sub.6, C.sub.7, C.sub.8, C.sub.9 or C.sub.10, a linear or ramified acyl group C.sub.1 -C.
    Type: Grant
    Filed: August 23, 1985
    Date of Patent: January 27, 1987
    Assignee: Continental Pharma Inc.
    Inventors: Romeo Roncucci, Claude L. Gillet, Alexis H. Cordi, Mark A. Martens, Joseph L. Roba, Paul J. Niebes, Georges E. Lambelin, William R. Van Dorsser
  • Patent number: 4562205
    Abstract: 2-Pentanoylaminoacetic acid and pharmaceutically suitable salts thereof are claimed for use as pharmaceuticals.The compounds are useful in producing an effect on the central nervous system, especially in the treatment of various forms of epilepsy, of disninesiae, of parkinsonism, of memory troubles, of psychic troubles and of cerebral anoxia.
    Type: Grant
    Filed: June 25, 1984
    Date of Patent: December 31, 1985
    Assignee: Continental Pharma Inc.
    Inventors: Robert G. Cavalier, Alexis A. Cordi, Claude L. Gillet, Philippe M. Janssens de Varebeke, Paul J. Niebes, Joseph L. Roba, William R. Van Dorsser, Georges E. Lambelin, Michel R. Franz
  • Patent number: 4507314
    Abstract: Drug for treating affections provoked by a too high histamine level in the body, for treating affections of the gastroduodenal mucosa and allergic affections, comprising the reaction product of (+)-catechin with at least one basic amino-acid, which is more particularly selected from the group consisting of L-lysine, L-arginine and L-ornithine.
    Type: Grant
    Filed: July 20, 1983
    Date of Patent: March 26, 1985
    Assignee: Midit, Societe Fiduciaire
    Inventors: Paul J. Niebes, Daniel M. Matagne, Etienne P. Hanon, Joseph L. Roba, Georges E. Lambelin
  • Patent number: 4268517
    Abstract: A pharmaceutical composition for treating degenerative diseases of the articular cartilage, in particular osteoarthritis and chondromalacia, and of the degenerative processes of the articular cartilage resulting from other diseases, such as rheumatoid arthritis, this composition containing (+) - catechin and/or one of the salts thereof as an active products, said composition being administered orally, rectally, intra-articularly, intravenously or topically.
    Type: Grant
    Filed: August 30, 1979
    Date of Patent: May 19, 1981
    Assignee: Continental Pharma
    Inventors: Paul J. Niebes, Andras B. Vincze, Joseph L. Roba, Georges E. Lambelin, Daniel M. Matagne, Etienne T. Hanon, Michel R. Franz